Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Watson

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Plos One|December 20, 2012
Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomesClaire Corcoran, Sweta Rani, Keith O'Brien, et al.
Royal Society Open Science|May 7, 2016
Correction to 'Food limitation of sea lion pups and the decline of forage off central and southern California'Sam McClatchie, John Field, Andrew R Thompson, et al.
Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.
Journal of Clinical Pathology|June 12, 2021
Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancerJenny Fitzgerald, Debra Higgins, Claudia Mazo Vargas, et al.
Oncotarget|October 1, 2016
Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potentialEamon P Mulvaney, Christine Shilling, Sarah B Eivers, et al.
Proteomics|May 25, 2012
The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell linesKathleen O'Connell, Maria Prencipe, Amanda O'Neill, et al.
Annals of Emergency Medicine|January 25, 2006
Early detection of illness associated with poisonings of public health significanceAmy F Wolkin, Manish Patel, William Watson, et al.
International Journal of Molecular Sciences|December 8, 2020
Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput <i>N</i>-Glycan ProfilingSarah Gilgunn, Keefe Murphy, Henning Stöckmann, et al.
NMR in Biomedicine|December 11, 2012
The evolution of traumatic brain injury in a rat focal contusion modelL Christine Turtzo, Matthew D Budde, Eric M Gold, et al.
The Prostate|August 8, 2015
Relationship between serum response factor and androgen receptor in prostate cancerMaria Prencipe, Amanda O'Neill, Gillian O'Hurley, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Plos One|December 20, 2012
Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomesClaire Corcoran, Sweta Rani, Keith O'Brien, et al.
Royal Society Open Science|May 7, 2016
Correction to 'Food limitation of sea lion pups and the decline of forage off central and southern California'Sam McClatchie, John Field, Andrew R Thompson, et al.
Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.
Journal of Clinical Pathology|June 12, 2021
Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancerJenny Fitzgerald, Debra Higgins, Claudia Mazo Vargas, et al.
Oncotarget|October 1, 2016
Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potentialEamon P Mulvaney, Christine Shilling, Sarah B Eivers, et al.
Proteomics|May 25, 2012
The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell linesKathleen O'Connell, Maria Prencipe, Amanda O'Neill, et al.
Annals of Emergency Medicine|January 25, 2006
Early detection of illness associated with poisonings of public health significanceAmy F Wolkin, Manish Patel, William Watson, et al.
International Journal of Molecular Sciences|December 8, 2020
Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput <i>N</i>-Glycan ProfilingSarah Gilgunn, Keefe Murphy, Henning Stöckmann, et al.
NMR in Biomedicine|December 11, 2012
The evolution of traumatic brain injury in a rat focal contusion modelL Christine Turtzo, Matthew D Budde, Eric M Gold, et al.
The Prostate|August 8, 2015
Relationship between serum response factor and androgen receptor in prostate cancerMaria Prencipe, Amanda O'Neill, Gillian O'Hurley, et al.
Pageof 12